PATENT CLAIM ANALYSIS

Application Number: 16069961
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "338000"]

Abstract:
Provided are novel compounds of Formula I pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders associated with mast cells. Also provided are pharmaceutical compositions comprising the novel compounds of Formula I and methods for their use in treating one or more diseases and disorders associated with mast cells.

Claim (Index 10):
A method of delaying the onset of, reversing, or reducing the risk of acquiring peripheral neuropathy (PN) in a subject having diabetes, comprising administering to the subject an effective amount of a compound having the Formula: or a pharmaceutically acceptable salt thereof, polymorph, or solvate thereof, wherein\n Z is CR 3  or N; \n X is CO and Y is NH, or X is NH and Y is CO; \n Cy is phenyl or monocyclic heteroaryl; \n R 1  and R 2  are each independently selected from (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkoxy, halo, and cyano; \n R 3  is hydrogen or (C 1 -C 4 )alkyl; and \n p and s are each independently 0, 1, 2, 3, or 4.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 95.0
- Lexical Diversity: 1.63158
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14422419', '12968608', '15105316', '14116199', '14409151']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7733475864825918
- 35 USC 102 Novelty (BERT): 0.5106902364317575
- Combined Prediction Score: 0.7470818514775085
- Mean Citation Score: 227.892358
- Max Citation Score: 233.9744
- Similarity Product: 138.11109134063722

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test